Cargando…
T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients
Introduction: Restriction factors (RFs) suppress HIV-1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood-derived mo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964667/ https://www.ncbi.nlm.nih.gov/pubmed/28953327 http://dx.doi.org/10.7448/IAS.20.1.21865 |
_version_ | 1783325222295830528 |
---|---|
author | Bolduan, Sebastian Koppensteiner, Herwig Businger, Ramona Rebensburg, Stephanie Kunze, Christine Brack-Werner, Ruth Draenert, Rika Schindler, Michael |
author_facet | Bolduan, Sebastian Koppensteiner, Herwig Businger, Ramona Rebensburg, Stephanie Kunze, Christine Brack-Werner, Ruth Draenert, Rika Schindler, Michael |
author_sort | Bolduan, Sebastian |
collection | PubMed |
description | Introduction: Restriction factors (RFs) suppress HIV-1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood-derived mononuclear cells (PBMC) from therapy-naïve HIV-1 patients and quantified infection. Results: Overall, there was no correlation between individual RF expression and HIV-1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2(low) T cells with reduced RF expression were markedly positive for HIV-1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2(low) T cell infection correlated with viral loads and was associated with HIV-1 disease progression. Conclusions: In untreated therapy naïve chronic HIV-1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV-1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention. |
format | Online Article Text |
id | pubmed-5964667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-59646672018-05-30 T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients Bolduan, Sebastian Koppensteiner, Herwig Businger, Ramona Rebensburg, Stephanie Kunze, Christine Brack-Werner, Ruth Draenert, Rika Schindler, Michael J Int AIDS Soc Research Article Introduction: Restriction factors (RFs) suppress HIV-1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood-derived mononuclear cells (PBMC) from therapy-naïve HIV-1 patients and quantified infection. Results: Overall, there was no correlation between individual RF expression and HIV-1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2(low) T cells with reduced RF expression were markedly positive for HIV-1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2(low) T cell infection correlated with viral loads and was associated with HIV-1 disease progression. Conclusions: In untreated therapy naïve chronic HIV-1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV-1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention. Taylor & Francis 2017-09-19 /pmc/articles/PMC5964667/ /pubmed/28953327 http://dx.doi.org/10.7448/IAS.20.1.21865 Text en © Bolduan S et al; licensee International AIDS Society. http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bolduan, Sebastian Koppensteiner, Herwig Businger, Ramona Rebensburg, Stephanie Kunze, Christine Brack-Werner, Ruth Draenert, Rika Schindler, Michael T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients |
title | T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients |
title_full | T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients |
title_fullStr | T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients |
title_full_unstemmed | T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients |
title_short | T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients |
title_sort | t cells with low cd2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic hiv-1 patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964667/ https://www.ncbi.nlm.nih.gov/pubmed/28953327 http://dx.doi.org/10.7448/IAS.20.1.21865 |
work_keys_str_mv | AT bolduansebastian tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients AT koppensteinerherwig tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients AT busingerramona tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients AT rebensburgstephanie tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients AT kunzechristine tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients AT brackwernerruth tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients AT draenertrika tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients AT schindlermichael tcellswithlowcd2levelsexpressreducedrestrictionfactorsandarepreferentiallyinfectedintherapynaivechronichiv1patients |